All the votes have been counted
Before getting into what the results released by Tandem yesterday let me offer my congratulations to John Sheridan who announced his retirement yesterday. John took over the CEO position back in 2019 and like all of us has witness a wild ride for Tandem. It’s not an overstatement to say that Tandem more than any other insulin pump company has experienced their fair share of ups and downs. Enjoy retirement...
Preparing for the choppy waters ahead
It’s time to acknowledge a few obvious items for Insulet who reported earnings this morning. 1. They remain firmly upon the Iron Throne while growing at nearly twice the rate of their competitors. 2. They are taking full advantage of their scale. 3. They are learning from past mistakes. (A rare quality in this wacky world). 4. The Street won’t like it but they are also becoming more realistic about the road ahead admitting...
Is there a path forward?
For years now I have been saying there is room for a third player in CGM. Yes Dexcom and Abbott have a duopoly but that does not mean there is no room for a third option. The question is who that player will be and what will their platform look like. Will it be designed for non-insulin using Type 2’s? Will it come with a patient friendly user interface with...
Time to become self-aware
Yep November is Diabetes Awareness Month so expect an onslaught of posts on social media about helping people with diabetes. With diabetes growing at epidemic rates on a global basis and the most popular weight loss drugs coming from the diabetes pipeline I seriously doubt to many people are unaware of diabetes. But hey this has been going on for years and the fact that it’s a farce doesn’t seem...
It’s all about GLUCOSE
This coming Tuesday November 3rd American’s will head to the polls (actually it’s the last day to vote now) and based on the polls the overriding theme is what else but the economy. Back in 1992 Bill Clinton’s lead campaign strategist James Carvallle coined the phrase It’s the economy, stupid when he was asked what the upcoming election was all about. Well when it comes to the CGM market it’s...
The Patch Pump Conundrum
Yesterday afternoon Beta Bionics reported 3rd quarter results which capsulize the issues facing every Insulet competitor. As everyone knows by now Beta has the Mint coming and if you believe the company it’s going to taste very good. It’s an understatement to say the company is excited about the Mint and its potential. We however aren’t yet convinced not because we believe the Mint is a bad product rather the...
Time for Action
Before I get started today a housekeeping item. There have been some issues with our servers that we believe have been fixed. There is a post from Monday which is up on the site and available for reading, however the email notification for that post did not get sent out. Again we believe this issue has been solved. Ok now onto business and I encourage you to read this carefully and...